Feature partnership third party author requirements
When booking a Feature Partnership with European Pharmaceutical Review you are required to source a third-party article from a client of yours. The article should focus on a project that you have both worked on together, thereby highlighting your partnership.
The third-party article should from an organisation of your choice that matches the below criteria.
Type of organisation
AbbVie, AstraZeneca, Bayer BioNTech, Eli Lilly and Company, Gilead Sciences, GSK, Merck & Co. (MSD), Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceuticals etc.
Achilles Therapeutics, Astellas Gene Therapies, bluebird bio, MeiraGTx, Regeneron, Vertex Pharmaceuticals etc.
Contract Development/Manufacturing Organisations (CDMOs or CMOs)
Almac, Cambrex, Catalent, Lonza, Patheon, PCI Pharma, Recipharm AB, Samsung Biologics, WuXi Biologics etc.
Copenhagen University, Duke University, Harvard University, Imperial College London, University College London, University of Cambridge, University of Oxford, University of Manchester, University of Pennsylvania etc.
R&D or industry organisations
AMR Industry Alliance, BioPhorum, Centre for Process Innovation (CPI), European Federation of Pharmaceutical Industries and Associations, National Institute for Bioprocessing Research and Training (NIBRT), Pistoia Alliance etc.